Log in to save to my catalogue

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfa...

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3070396

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis

About this item

Full title

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis

Publisher

Oxford, UK: Oxford University Press

Journal title

Inflammatory bowel diseases, 2010-01, Vol.16 (1), p.87-95

Language

English

Formats

Publication information

Publisher

Oxford, UK: Oxford University Press

More information

Scope and Contents

Contents

Resolvin E1 (RvE1), an endogenous lipid mediator derived from eicosapentaenoic acid, has been identified in local inflammation during the healing stage. RvE1 reduces inflammation in several types of animal models including peritonitis and retinopathy and blocks human neutrophil transendothelial cell migration. The RvE1 receptor ChemR23 is expressed...

Alternative Titles

Full title

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3070396

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3070396

Other Identifiers

ISSN

1078-0998

E-ISSN

1536-4844

DOI

10.1002/ibd.21029

How to access this item